UISEE TECH (01511) and TOPNC (07688) have concluded their public offerings, while TENNOR THERAP-B (06872) remains in the subscription period. As of May 15, data from brokers including Futu Securities and Tiger Brokers shows that margin financing for UISEE TECH reached HKD 225.872 billion, representing an oversubscription of over 5,179.55 times. Financing for TOPNC amounted to HKD 499.141 billion, with an oversubscription exceeding 2,894.08 times. For TENNOR THERAP-B, margin financing stood at HKD 5.067 billion, indicating an oversubscription of more than 79.83 times.